Nerissa Kreher - 29 Dec 2021 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role: Chief Medical Officer
Signature: /s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol: TRDA
Transactions as of: 29 Dec 2021
Net transactions value: +$10,920
Form type: 4
Filing time: 29 Dec 2021, 15:26:17 UTC
Previous filing: 28 Oct 2021
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TRDA	Common Stock	Options Exercise	$10,920	+5,200		$2.10^*	5,200	29 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TRDA	Stock Option (Right to Buy)	Exercise of in-the-money or at-the-money derivative security	$0	-5,200	-3.5%	$0.000000	142,722	29 Dec 2021	Common Stock	5,200	$2.10	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to this option vested and became exercisable on December 7, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.